Amgen’s Stock Outlook: Balancing Maritide’s Weight Loss Data Concerns and Diabetes Treatment Potential
Analyst Mohit Bansal of Wells Fargo maintained a Hold rating on Amgen (AMGN – Research Report), retaining the price target of $335.00.Don't ...
Amgen’s MariTide Phase 2 Success Drives Buy Rating Amid Promising Obesity Treatment Prospects
Goldman Sachs analyst Salveen Richter has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...
Stocktwits on MSN45m
Amgen Stock Slips After More Analyst Criticism On Weight-Loss Drug Data: Retail Eyes ‘Great Buying Opportunity’
Shares of Amgen Inc. ($AMGN) edged down 0.3% in premarket trading Wednesday, on course to extend a losing streak to a third ...
Yahoo Finance46m
At 9.6% CAGR Skull Clamps Market Size to Reach $4.33 Billion By 2031 | The Insight Partners
US & Canada, Nov. 27, 2024 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the Global ...
The Globe and Mail22m
Stocks Slip Before the Open With Focus on Key U.S. Inflation Data and Trump’s Picks
December S&P 500 E-Mini futures (ESZ24) are down -0.18%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.33% this morning as investors digested Donald Trump’s latest cabinet appointments ...
Lebanon PM Says Will Reinforce Army Presence In South After Truce
Lebanon's prime minister on Wednesday said the army will reinforce its presence in the south, urging Israel to withdraw and respect the terms of the ceasefire reached with Hezbollah.